Pure Global AI
NCT06255730Recruiting

The Effect of Stellate Ganglion Block on Insomnia Patients

The Effect of Stellate Ganglion Block on Insomnia Patients: a Pre - and Post Control Experiments
Zeng ChanghaoClinicalTrials.govprocedure
Verified
Study focus
Disease/Condition
Insomnia
Drug/Device/Intervention
Stellate Ganglion Block
Study type
Interventional
Intervention type
procedure
Sponsor & location
Primary sponsor
Zeng Changhao
Funder
People's Hospital of Zhengzhou University
Location
Seoul, South Korea
Timeline & enrollment
Phase
N/A
Start date
Feb 28, 2024
End date
Jun 01, 2024
Enrollment
50 participants
Primary outcome

Pittsburgh Sleep Quality Index

Summary

A prospective study was conducted on Insomnia Patients. All the patients were provided with
 Stellate Ganglion Block. The quality of sleep was evaluated to see if Stellate Ganglion Block
 can improve Insomnia.

ICD-10 classifications
Nonorganic insomniaDisorders of initiating and maintaining sleep [insomnias]Sleep disordersSleep disorder, unspecifiedOther sleep disorders
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06255730
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06255730 through Pure Global AI's free database. This phase not specified trial is sponsored by Zeng Changhao and is currently Recruiting. The study focuses on Insomnia. Target enrollment is 50 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.